Strengthening Reporting of Neonatal Trials

Webbe, James and Baba, Ami and Butcher, Nancy J. and Rodrigues, Craig and Stallwood, Emma and Goren, Katherine and Monsour, Andrea and Chang, Alvin S. M. and Trivedi, Amit and Manley, Brett J. and McCall, Emma and Bogossian, Fiona and Namba, Fumihiko and Schmoelzer, Georg M. and Popat, Himanshu and Nguyen, Kim An and Doyle, Lex W. and Jardine, Luke and Rysavy, Matthew A. and Konstantinidis, Menelaos and Helmi, Muhd Alwi Muhd and Lai, Nai Ming and Hay, Susanne and Onland, Wes and Choo, Yao Mun and Gale, Chris and Soll, Roger F. and Offringa, Martin and Tr, Core Outcome Reporting Neonatal (2023) Strengthening Reporting of Neonatal Trials. Pediatrics, 152 (3). ISSN 0031-4005, DOI https://doi.org/10.1542/peds.2022-060765.

Full text not available from this repository.

Abstract

BACKGROUND AND OBJECTIVES: There is variability in the selection and reporting of outcomes in neonatal trials with key information frequently omitted. This can impact applicability of trial findings to clinicians, families, and caregivers, and impair evidence synthesis. The Neonatal Core Outcomes Set describes outcomes agreed as clinically important that should be assessed in all neonatal trials, and Consolidated Standards of Reporting Trials (CONSORT)-Outcomes 2022 is a new, harmonized, evidence-based reporting guideline for trial outcomes. We reviewed published trials using CONSORT-Outcomes 2022 guidance to identify exemplars of neonatal core outcome reporting to strengthen description of outcomes in future trial publications. METHODS: Neonatal trials including >100 participants per arm published between 2015 to 2020 with a primary outcome included in the Neonatal Core Outcome Set were identified. Primary outcome reporting was reviewed using CONSORT 2010 and CONSORT-Outcomes 2022 guidelines by assessors recruited from Cochrane Neonatal. Examples of clear and complete outcome reporting were identified with verbatim text extracted from trial reports. RESULTS: Thirty-six trials were reviewed by 39 assessors. Examples of good reporting for CONSORT 2010 and CONSORT-Outcomes 2022 criteria were identified and subdivided into 3 outcome categories: ``survival,'' ``short-term neonatal complications,'' and ``long-term developmental outcomes'' depending on the core outcomes to which they relate. These examples are presented to strengthen future research reporting. CONCLUSIONS: We have identified examples of good trial outcome reporting. These illustrate how important neonatal outcomes should be reported to meet the CONSORT 2010 and CONSORT-Outcomes 2022 guidelines. Emulating these examples will improve the transmission of information relating to outcomes and reduce associated research waste.

Item Type: Article
Funders: UNSPECIFIED
Subjects: R Medicine > R Medicine (General)
R Medicine > RJ Pediatrics
Divisions: Faculty of Medicine > Paediatrics Department
Depositing User: Ms. Juhaida Abd Rahim
Date Deposited: 20 Aug 2025 07:54
Last Modified: 20 Aug 2025 07:54
URI: http://eprints.um.edu.my/id/eprint/50669

Actions (login required)

View Item View Item